Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Photodynamic Therapy for the Most Common Skin Cancer Wins Approval

(MedPage Today) -- The FDA approved aminolevulinic acid hydrochloride 10% (Ameluz) in combination with photodynamic therapy for treating adults with superficial basal cell carcinoma, maker Biofrontera announced on Monday. The approval represents...

Photodynamic Therapy for the Most Common Skin Cancer Wins Approval

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Researchers on mission to improve heat illness data at A&Es in Singapore

Several hospitals and residential homes have also been taking more measures to protect patients during hotter weather.

  • Singapore researchers collaborate with 10 public hospitals to improve heat illness data collection
  • HEAT-MAP study aims to forecast future heat threats amid global warming
  • Heat-related illness cases in Singapore increased from 280 in 2024 to 398 in 2025

More from Monday 14 September →